Physician

Akhilesh Wadhwa, M.D.

According to 2025 Medicare claims, Akhilesh Wadhwa, M.D. (NPI: 1942657010) practices internal medicine in the Cheyenne, WY market, with the plurality of this provider's patient population coming from Laramie, WY. This provider's primary affiliated billing organization is CHEYENNE REGIONAL PHYSICIANS GROUP, LLC (NPI: 1659458008; TIN: 205551661) and primary practice location at 82001-3884. Wadhwa is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Wadhwa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 387 traditional Medicare patients, billed 4,091 HCPCS/CPT codes, and received $140,115 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,051 prescription claims across 351 beneficiaries totaling $1,606,767 in drug costs, led by Ozempic (Semaglutide). DME data shows 606 claims. Open Payments data shows 55 records totaling $1,146. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $3,421 to $1,606,767. For DME billing, reported payments moved sharply higher in recent years, from $752 to $220,508.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$70K$140K2021 Medicare payment: $15,112 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $99,689 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $128,152 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $140,115 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202173211$15,112
20224562,146$99,689
20234963,309$128,152
20243874,091$140,115

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$803K$1.6M2016 Drug cost: $3,421 (USD; Tot_Drug_Cst)2017 Drug cost: $12,283 (USD; Tot_Drug_Cst)2018 Drug cost: $8,755 (USD; Tot_Drug_Cst)2019 Drug cost: $4,790 (USD; Tot_Drug_Cst)2021 Drug cost: $63,825 (USD; Tot_Drug_Cst)2022 Drug cost: $772,054 (USD; Tot_Drug_Cst)2023 Drug cost: $1,506,453 (USD; Tot_Drug_Cst)2024 Drug cost: $1,606,767 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161147$3,421
20172889$12,283
201835123$8,755
201923108$4,790
2020N/RN/RN/R
202179207$63,825
20222531,582$772,054
20233433,232$1,506,453
20243514,051$1,606,767

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$114K$228K2022 Medicare payment: $44,931 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $144,007 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $228,215 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202295299$44,931
2023150785$144,007
2024178606$228,215

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more349785$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3446$56
95249Continuous monitoring of blood sugar level in tissue fluid using sensor under skin2222$50
95251Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report134469$26
83036Hemoglobin a1c level217465$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OzempicSemaglutide34112,677$408,107
JardianceEmpagliflozin37014,952$290,825
MounjaroTirzepatide1715,124$183,796
TrulicityDulaglutide1564,956$163,490
JanuviaSitagliptin Phosphate993,911$73,238

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceN108376$191,489
J1817Insulin for administration through dme (i.e., insulin pump) per 50 unitsNN/R30$7,898
E2103Non-adjunctive, non-implanted continuous glucose monitor or receiverN3535$7,351
A4224Supplies for maintenance of insulin infusion catheter, per weekNN/R31$7,062
A4238Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceNN/R18$6,321

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.55$1,146Boehringer Ingelheim Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Akhilesh Wadhwa, M.D.?

Tedicare shows public-source Medicare data for Akhilesh Wadhwa, M.D. (NPI 1942657010), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akhilesh Wadhwa, M.D. have ACO affiliation data?

Akhilesh Wadhwa, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Akhilesh Wadhwa, M.D.?

Akhilesh Wadhwa, M.D. is linked to CHEYENNE REGIONAL PHYSICIANS GROUP, LLC (billing NPI 1659458008) in the available physician profile data.

Does Akhilesh Wadhwa, M.D. have Open Payments data?

Akhilesh Wadhwa, M.D. has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.